CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Clinical trials for CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) trials appear
Sign up with your email to follow new studies for CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial for Hard-to-Treat leukemia shows early promise
Disease control TerminatedThis study tested an experimental drug called NMS-03592088 in adults with acute myeloid leukemia (AML) or chronic myelomonocytic leukemia (CMML) that had come back or stopped responding to standard treatments. The goal was to find the safest dose and see if the drug could help co…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Phase: PHASE1, PHASE2 • Sponsor: Nerviano Medical Sciences • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Experimental cancer drug trial halted early – what happened?
Disease control TerminatedThis study tested a new drug called S227928, alone or with another drug (venetoclax), in 13 people with blood cancers that had come back or stopped responding to treatment. The goal was to find a safe dose and see if it could shrink the cancer. The trial was stopped early, so res…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Phase: PHASE1, PHASE2 • Sponsor: Servier Bio-Innovation LLC • Aim: Disease control
Last updated May 15, 2026 11:53 UTC